Amylyx Pharmaceuticals (AMLX) News Today $5.24 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating Upgraded by Baird R WBaird R W raised shares of Amylyx Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a research note on Monday.November 19 at 6:31 AM | marketbeat.comBaird Upgrades Amylyx Pharmaceuticals (AMLX)November 19 at 4:19 AM | msn.comTwist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On MondayNovember 18 at 11:19 PM | benzinga.comAmylyx upgraded to Outperform from Neutral at BairdNovember 18 at 11:19 PM | markets.businessinsider.comStrong Buy Rating for Amylyx Pharmaceuticals Inc. Driven by Promising Avexitide Prospects and Stable Financial StandingNovember 18 at 11:19 PM | markets.businessinsider.comAmylyx Pharmaceuticals upgraded to Outperform at Baird, shares riseNovember 18 at 11:19 PM | msn.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded by Robert W. Baird to Outperform RatingRobert W. Baird upgraded shares of Amylyx Pharmaceuticals from a "neutral" rating to an "outperform" rating and upped their price target for the company from $3.00 to $11.00 in a research note on Monday.November 18 at 8:32 AM | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest UpdateAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,290,000 shares, a growth of 27.7% from the October 15th total of 1,010,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is currently 1.0 days. Approximately 3.1% of the shares of the company are sold short.November 15, 2024 | marketbeat.comCautious Hold on Amylyx Pharmaceuticals Amid Uncertainty in Pipeline ProgressNovember 11, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comAmylyx Pharmaceuticals Q3 2024 Financial HighlightsNovember 9, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...November 8, 2024 | finance.yahoo.comHC Wainwright Issues Positive Forecast for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock PriceHC Wainwright raised their price objective on Amylyx Pharmaceuticals from $8.00 to $12.00 and gave the company a "buy" rating in a research note on Friday.November 8, 2024 | marketbeat.comAmylyx Pharmaceuticals (AMLX) to Release Earnings on ThursdayAmylyx Pharmaceuticals (NASDAQ:AMLX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 5, 2024 | marketbeat.comVentyx Biosciences: Ready To Escape "The Crash Cycle"November 5, 2024 | seekingalpha.comabrdn plc Has $6.39 Million Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)abrdn plc boosted its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 1,567.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,972,242 shares of the company's stock aftNovember 3, 2024 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Amylyx Pharmaceuticals Inc (AMLX)October 29, 2024 | markets.businessinsider.comPerceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals IncOctober 25, 2024 | finance.yahoo.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded at Bank of AmericaBank of America upgraded shares of Amylyx Pharmaceuticals from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $4.20 to $10.00 in a research report on Wednesday.October 23, 2024 | marketbeat.comNeutral Stance on Amylyx Pharmaceuticals Amid Promising Data and UncertaintiesOctober 23, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $8.00 price objective on shares of Amylyx Pharmaceuticals in a research report on Friday.October 18, 2024 | marketbeat.comWhy Amylyx Pharmaceuticals Stock Was So Healthy This WeekOctober 18, 2024 | fool.comMillennium Management LLC Has $2.92 Million Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Millennium Management LLC decreased its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 38.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,535,178 shares of the company's stock after seOctober 15, 2024 | marketbeat.comAmylyx Pharma (NASDAQ:AMLX) Stock, Short Interest ReportOctober 14, 2024 | benzinga.comAmylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Call Highlights: Strategic Pipeline ...October 9, 2024 | finance.yahoo.comAmerican Century Companies Inc. Reduces Stock Position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)American Century Companies Inc. cut its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 95.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,041 shares of the company's stock aftOctober 6, 2024 | marketbeat.comAmylyx Pharmaceuticals executive sells over $27k in company stockOctober 4, 2024 | investing.comAmylyx Pharmaceuticals executive sells over $36k in company stockOctober 4, 2024 | investing.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Purchased by AQR Capital Management LLCAQR Capital Management LLC raised its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 2,768.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,340,943 shares of the company's stock aftOctober 4, 2024 | marketbeat.comKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmOctober 3, 2024 | prnewswire.comCamille L. Bedrosian Sells 11,442 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) StockOctober 3, 2024 | insidertrades.comInsider Selling: Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Insider Sells 11,442 Shares of StockAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) insider Camille L. Bedrosian sold 11,442 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $3.20, for a total value of $36,614.40. Following the completion of the transaction, the insider now directly owns 143,801 shares in the company, valued at approximately $460,163.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.October 2, 2024 | marketbeat.comAlmitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Almitas Capital LLC purchased a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,903,851 shares of the company's stock, valued at approxiSeptember 29, 2024 | marketbeat.comXTX Topco Ltd Purchases New Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)XTX Topco Ltd purchased a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 210,612 shares of the company's stock, valued at approSeptember 26, 2024 | marketbeat.comPharma Mar, S.A. (PMRA.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comReneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are BuyingSeptember 17, 2024 | benzinga.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO Acquires $101,200.00 in StockSeptember 17, 2024 | insidertrades.comKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmSeptember 16, 2024 | globenewswire.comShort Interest in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Declines By 24.4%Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 1,490,000 shares, a decline of 24.4% from the August 15th total of 1,970,000 shares. Approximately 3.6% of the company's stock are short sold. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is currently 0.9 days.September 15, 2024 | marketbeat.comAcadian Asset Management LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)Acadian Asset Management LLC purchased a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,211,617 shares of the companSeptember 14, 2024 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Hold" from AnalystsShares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) have been assigned an average rating of "Hold" from the eight ratings firms that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating and two have given a buy raSeptember 12, 2024 | marketbeat.comDirector Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)September 9, 2024 | finance.yahoo.comAmylyx Pharmaceuticals: Management Ambitiously Navigates ChallengesSeptember 9, 2024 | seekingalpha.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director George M. Milne, Jr. Purchases 100,000 SharesSeptember 6, 2024 | insidertrades.comDirector MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)September 6, 2024 | finance.yahoo.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director Purchases $220,000.00 in StockAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) Director George M. Milne, Jr. acquired 100,000 shares of the firm's stock in a transaction on Tuesday, September 3rd. The shares were bought at an average cost of $2.20 per share, with a total value of $220,000.00. Following the completion of the acquisition, the director now owns 858,571 shares in the company, valued at $1,888,856.20. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.September 5, 2024 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Significant Growth in Short InterestAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) saw a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,970,000 shares, an increase of 5.9% from the July 31st total of 1,860,000 shares. Based on an average daily volume of 1,670,000 shares, the days-to-cover ratio is currently 1.2 days. Currently, 4.3% of the company's stock are short sold.September 2, 2024 | marketbeat.comCautious Optimism Amidst Uncertainty: Assessing Amylyx Pharmaceuticals’ Future ProspectsAugust 14, 2024 | markets.businessinsider.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Down 50.8% in JulyAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,860,000 shares, a decline of 50.8% from the July 15th total of 3,780,000 shares. Based on an average daily trading volume, of 1,730,000 shares, the short-interest ratio is currently 1.1 days. Approximately 4.1% of the shares of the company are short sold.August 13, 2024 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | msn.com Get Amylyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. AMLX Media Mentions By Week AMLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMLX News Sentiment▼0.920.48▲Average Medical News Sentiment AMLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMLX Articles This Week▼106▲AMLX Articles Average Week Get Amylyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intellia Therapeutics News Today Spyre Therapeutics News Today Praxis Precision Medicines News Today Day One Biopharmaceuticals News Today Ocular Therapeutix News Today Syndax Pharmaceuticals News Today Arcus Biosciences News Today ARS Pharmaceuticals News Today Ardelyx News Today Arcutis Biotherapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free amlx Stock Alerts